Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.69
Delayed Data
As of Apr 24
 -0.28 / -9.43%
Today’s Change
1.85
Today|||52-Week Range
4.97
+1.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-47.4M-62.8M-90.2M-86.2M
 
 
 
 
 
Depreciation1.5M738.0K516.0K673.0K
 
 
 
 
 
Total Other Cash Flow3.4M3.3M6.0M7.4M
 
 
 
 
 
Funds From Operations-42.6M-58.7M-83.6M-78.1M
 
 
 
 
 
Funds From/For Other Operating Expenses4.7M-4.6M-6.2M868.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-47.3M-54.1M-77.4M-78.9M
 
 
 
 
 
 
InvestingIncrease In Investments-50.7M-50.0M-114.2M-93.8M
 
 
 
 
 
Decrease In Investments60.7M40.6M90.3M85.2M
 
 
 
 
 
Capital Expenditures-690.0K-505.0K-769.0K-144.0K
 
 
 
 
 
Net Cash Flow Investing9.3M-9.9M-24.7M-8.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings2.0M0.0013.5M0.00
 
 
 
Long Term Debt Reduction-579.0K-4.2M-2.6M-9.5M
 
 
 
 
 
Net Proceeds Stock Sale35.3M119.8M58.2M94.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.0032.0K0.000.00
 
 
Net Cash Flow - Financing36.7M115.5M69.0M85.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash-1.2M51.4M-33.0M-2.5M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account